349 related articles for article (PubMed ID: 10863066)
21. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
22. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
23. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
25. The influence of interpatient and intrapatient rectum variation on external beam treatment of prostate cancer.
Yan D; Xu B; Lockman D; Kota K; Brabbins DS; Wong J; Martinez AA
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1111-9. PubMed ID: 11704336
[TBL] [Abstract][Full Text] [Related]
26. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer.
Lebesque JV; Bruce AM; Kroes AP; Touw A; Shouman RT; van Herk M
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1109-19. PubMed ID: 7493837
[TBL] [Abstract][Full Text] [Related]
27. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer.
Saarnak AE; Boersma M; van Bunningen BN; Wolterink R; Steggerda MJ
Radiother Oncol; 2000 Jul; 56(1):37-42. PubMed ID: 10869753
[TBL] [Abstract][Full Text] [Related]
28. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
Koelbl O; Richter S; Flentje M
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
[TBL] [Abstract][Full Text] [Related]
29. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
[TBL] [Abstract][Full Text] [Related]
30. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
[TBL] [Abstract][Full Text] [Related]
31. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
32. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
Kim HJ; Kim S; Ha SW; Wu HG
Tumori; 2008; 94(3):327-32. PubMed ID: 18705399
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
34. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
35. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.
Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618
[TBL] [Abstract][Full Text] [Related]
36. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.
Datta NR; Srivastava A; Maria Das KJ; Gupta A; Rastogi N
Brachytherapy; 2006; 5(4):223-9. PubMed ID: 17118314
[TBL] [Abstract][Full Text] [Related]
37. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
[TBL] [Abstract][Full Text] [Related]
38. Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer.
Georg P; Boni A; Ghabuous A; Goldner G; Schmid MP; Georg D; Pötter R; Dörr W
Strahlenther Onkol; 2013 Jul; 189(7):535-40. PubMed ID: 23703404
[TBL] [Abstract][Full Text] [Related]
39. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability.
Fiorino C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Piazzolla A; Cozzarini C
Radiother Oncol; 2002 Jun; 63(3):249-55. PubMed ID: 12142088
[TBL] [Abstract][Full Text] [Related]
40. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
